Assessing behavioral adverse events in patients taking brivaracetam

Описание к видео Assessing behavioral adverse events in patients taking brivaracetam

Kimford Meador, MD, FAAN, Stanford University, Stanford, CA, presents results from a retrospective study assessing the habituation of adverse events in patients with seizures receiving brivaracetam. Whilst brivaracetam is effective and well tolerated, side effects relating behavioral disorders did not habituate in the same fashion as cognitive effects such as mental acuity, which typically disappear over time. This interview took place at the American Academy of Neurology 2022 Congress in Seattle, WA.

Комментарии

Информация по комментариям в разработке